APA (7th ed.) Citation

I, G., RL, B., & JK, B. (2013). Does CALU SNP rs1043550 contribute variability to therapeutic warfarin dosing requirements? Clinical medicine & research, 11(2), 73. https://doi.org/10.3121/cmr.2013.1130

Chicago Style (17th ed.) Citation

I, Glurich, Berg RL, and Burmester JK. "Does CALU SNP Rs1043550 Contribute Variability to Therapeutic Warfarin Dosing Requirements?" Clinical Medicine & Research 11, no. 2 (2013): 73. https://doi.org/10.3121/cmr.2013.1130.

MLA (9th ed.) Citation

I, Glurich, et al. "Does CALU SNP Rs1043550 Contribute Variability to Therapeutic Warfarin Dosing Requirements?" Clinical Medicine & Research, vol. 11, no. 2, 2013, p. 73, https://doi.org/10.3121/cmr.2013.1130.